# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-034575
Filing Date
2025-03-06
Accepted
2025-03-06 16:01:55
Documents
100
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | ctmx-20241231.htm iXBRL | 10-K | 3690265
2 | EX-23.1 | ctmx-ex23_1.htm | EX-23.1 | 7547
3 | EX-31.1 | ctmx-ex31_1.htm | EX-31.1 | 15032
4 | EX-31.2 | ctmx-ex31_2.htm | EX-31.2 | 14819
5 | EX-32.1 | ctmx-ex32_1.htm | EX-32.1 | 12365
6 | GRAPHIC | img241899024_0.jpg | GRAPHIC | 83263
7 | GRAPHIC | img241899024_1.jpg | GRAPHIC | 75698
8 | GRAPHIC | img241899024_2.jpg | GRAPHIC | 138758
| Complete submission text file | 0000950170-25-034575.txt |  | 14369550

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ctmx-20241231.xsd | EX-101.SCH | 1848475
103 | EXTRACTED XBRL INSTANCE DOCUMENT | ctmx-20241231_htm.xml | XML | 2356515

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37587 | Film No.: 25715108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)